MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/acn3.51922

Медицинская библиотека · Annals of clinical and translational neurology · 2023

Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy.

Geuens Sam, Van Dessel Jeroen, Govaarts Rosanne, Ikelaar Nadine A, Meijer Onno C, Kan Hermien E, Niks Erik H, Goemans Nathalie, Lemiere Jurgen, Doorenweerd Nathalie, De Waele Liesbeth

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Duchenne muscular dystrophy (DMD) is a neuromuscular disorder in which many patients also have neurobehavioral problems. Corticosteroids, the primary pharmacological treatment for DMD, have been shown to affect brain morphology in other conditions, but data in DMD are lacking. This study aimed to investigate the impact of two corticosteroid regimens on brain volumetrics in DMD using magnetic resonance imaging (MRI).

METHODS

In a cross-sectional, two-center study, T1-weighted MRI scans were obtained from three age-matched groups (9-18 years): DMD patients treated daily with deflazacort (DMDd, n = 20, scan site: Leuven), DMD patients treated intermittently with prednisone (DMDi, n = 20, scan site: Leiden), and healthy controls (n = 40, both scan sites). FSL was used to perform voxel-based morphometry analyses and to calculate intracranial, total brain, gray matter, white matter, and cerebrospinal fluid volumes. A MANCOVA was employed to compare global volumetrics between groups, with site as covariate.

RESULTS

Both patient groups displayed regional differences in gray matter volumes compared to the control group. The DMDd group showed a wider extent of brain regions affected and a greater difference overall. This was substantiated by the global volume quantification: the DMDd group, but not the DMDi group, showed significant differences in gray matter, white matter, and cerebrospinal fluid volumes compared to the control group, after correction for intracranial volume.

INTERPRETATION: Volumetric differences in the brain are considered part of the DMD phenotype. This study suggests an additional impact of corticosteroid treatment showing a contrast between pronounced alterations seen in patients receiving daily corticosteroid treatment and more subtle differences in those treated intermittently.

Для цитирования: Geuens Sam, Van Dessel Jeroen, Govaarts Rosanne, Ikelaar Nadine A, Meijer Onno C, Kan Hermien E, Niks Erik H, Goemans Nathalie, Lemiere Jurgen, Doorenweerd Nathalie, De Waele Liesbeth. Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy.. Annals of clinical and translational neurology. 2023. DOI: 10.1002/acn3.51922.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.